SCHEMBL11030281

SCHEMBL11030281

Cc1ccc2c(c1Br)/C(=N\NC(=O)c1cc(O)cc(O)c1)C(=O)N2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
MAPT P10636 2/20 0.46
HTT P42858 1/20 0.46
AGTR1 P30556 3/20 0.46
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
POLB P06746 3/20 0.39
TDP1 Q9NUW8 2/20 0.39
CTDSP1 Q9GZU7 1/20 0.39
MTOR P42345 2/20 0.36
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
TP53 P04637 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
DNMT1 P26358 1/20 0.32
DUSP3 P51452 1/20 0.32
PTPN5 P54829 1/20 0.32
PTPN11 Q06124 1/20 0.32
MCL1 Q07820 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11030290 1.00 ALDH1A1 (0.46) ALDH1A1MAPTHTTAGTR1KMT2A
SCHEMBL11025683 0.75 ALDH1A1 (0.52) ALDH1A1MAPTHTTAGTR1KMT2A
SCHEMBL11025717 0.75 ALDH1A1 (0.52) ALDH1A1MAPTHTTAGTR1KMT2A
SCHEMBL11028130 0.73 MAPT (0.60) ALDH1A1MAPTHTTAGTR1KMT2A
SCHEMBL11028131 0.73 MAPT (0.60) ALDH1A1MAPTHTTAGTR1KMT2A
SCHEMBL16211074 0.72 ALDH1A1 (0.43) ALDH1A1MAPTHTTAGTR1KMT2A
SCHEMBL12127344 0.72 AGTR1 (0.53) ALDH1A1MAPTHTTAGTR1KMT2A
SCHEMBL16211072 0.72 ALDH1A1 (0.43) ALDH1A1MAPTHTTAGTR1KMT2A
SCHEMBL11027185 0.71 ALDH1A1 (0.58) ALDH1A1MAPTHTTAGTR1KMT2A
SCHEMBL11027188 0.71 ALDH1A1 (0.58) ALDH1A1MAPTHTTAGTR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120190009-A1 Viral Modulators and Processes Thereof KASHANCHI FATAH (US) 2012-07-26 US disclosed
US-20120190009-A1 Viral Modulators and Processes Thereof KASHANCHI FATAH (US) 2012-07-26 US disclosed
US-20120190723-A1 VIRAL MODULATORS AND PROCESSES THEREOF KASHANCHI FATAH (US) 2012-07-26 US disclosed
US-20120190723-A1 VIRAL MODULATORS AND PROCESSES THEREOF KASHANCHI FATAH (US) 2012-07-26 US disclosed
US-20120190723-A1 VIRAL MODULATORS AND PROCESSES THEREOF KASHANCHI FATAH (US) 2012-07-26 US disclosed
US-20120190009-A1 Viral Modulators and Processes Thereof KASHANCHI FATAH (US) 2012-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190723-A1 VIRAL MODULATORS AND PROCESSES THEREOF MAVS, HAVCR2, HDLBP ALDH1A1 4453/4885MAPT 1778/4885HTT 3934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.